THE HEMOPURIFIER® THE HEMOPURIFIER® IN INFECTIOUS DISEASE THE HEMOPURIFIER® IN CANCER
用免疫治疗技术防治传染病和癌症
在艾特龙医疗,我们是一个领先的开发免疫治疗技术,以对抗传染病和癌症。为了增强身体的自然免疫防御,Aethlon Hemopurifier®消除威胁生命的疾病靶点,这些靶点通常被免疫系统所保护,而传统药物疗法并没有很好地解决这些问题。该技术通过与一种独特的结构的亲和附着来捕获循环中的病毒、细菌毒素和癌症促进外泌体,从而使这些目标免受免疫检测。目前,Hemopurifier®正在FDA批准的临床研究中进行。Aethlon也是Exosome Sciences, Inc.的主要所有者,该公司专注于外泌体生物标志物的发现,以诊断和监测危及生命的疾病。
Combating Infectious Disease and Cancer with Immunotherapeutic Technologies At Aethlon Medical, we are a leading developer of immunotherapeutic technologies to combat infectious disease and cancer. To augment the body's natural immune defenses, the Aethlon Hemopurifier® eliminates life-threatening disease targets that are often shielded from the immune system and not well addressed by traditional drug therapies. The technology captures circulating viruses, bacterial toxins and cancer promoting exosomes through affinity attachment to a unique structure that cloaks these targets from immune detection. At present, the Hemopurifier® is being advanced under an FDA approved clinical study. Aethlon is also the majority owner of Exosome Sciences, Inc., a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.